Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial-Mesenchymal Transition Regulated by miR-200 in Breast Cancer Cells

Cancer Research - United States
doi 10.1158/0008-5472.can-10-0965
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial and Mesenchymal Phenotype Conversions in Breast Cancer

Cancer Research
Cancer ResearchOncology
2009English

The Role of the miR-200 Family in Epithelial-Mesenchymal Transition

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2010English

Complement Component 3 Is Regulated by TWIST1 and Mediates Epithelial–Mesenchymal Transition

Journal of Immunology
AllergyImmunology
2015English

Interleukin-6 Induces Epithelial-Mesenchymal Transition in Breast Cancer Cells

Gaceta Mexicana de Oncolog�a
2019English

CCL20 Mediates RANK/RANKL-induced Epithelial-Mesenchymal Transition in Endometrial Cancer Cells

Oncotarget
Oncology
2016English

miR‑30a Inhibits Epithelial‑mesenchymal Transition and Metastasis in Triple‑negative Breast Cancer by Targeting ROR1

Oncology Reports
MedicineCancer ResearchOncology
2018English

miR-573 Inhibits Prostate Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition

Oncotarget
Oncology
2015English

miR-15b Promotes Epithelial-Mesenchymal Transition by Inhibiting SMURF2 in Pancreatic Cancer

International Journal of Oncology
Cancer ResearchOncology
2015English

Loss of CLCA4 Promotes Epithelial-To-Mesenchymal Transition in Breast Cancer Cells

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy